Cellular metabolism and pore lifetime of human skin following microprojection array mediation

Journal Article (2019)
Author(s)

Isha N. Haridass (Curtin University, University of Queensland)

Jonathan C.J. Wei (TU Delft - Medical Instruments & Bio-Inspired Technology, University of Queensland)

Yousuf H. Mohammed (University of Queensland)

Michael L. Crichton (Heriot-Watt University)

Christopher D. Anderson (Linköping University)

Joakim Henricson (Linköping University)

Washington Y. Sanchez (University of Queensland)

Stefano C. Meliga (University of Queensland)

Jeffrey E. Grice (University of Queensland)

Heather A.E. Benson (Curtin University)

Mark A.F. Kendall (University of Queensland, Australian National University)

Michael S. Roberts (University of South Australia, University of Queensland)

Research Group
Medical Instruments & Bio-Inspired Technology
DOI related publication
https://doi.org/10.1016/j.jconrel.2019.05.024 Final published version
More Info
expand_more
Publication Year
2019
Language
English
Research Group
Medical Instruments & Bio-Inspired Technology
Volume number
306
Pages (from-to)
59-68
Downloads counter
233

Abstract

Skin-targeting microscale medical devices are becoming popular for therapeutic delivery and diagnosis. We used cryo-SEM, fluorescence lifetime imaging microscopy (FLIM), autofluorescence imaging microscopy and inflammatory response to study the puncturing and recovery of human skin ex vivo and in vivo after discretised puncturing by a microneedle array (Nanopatch®). Pores induced by the microprojections were found to close by ~25% in diameter within the first 30 min, and almost completely close by ~6 h. FLIM images of ex vivo viable epidermis showed a stable fluorescence lifetime for unpatched areas of ~1000 ps up to 24 h. Only the cells in the immediate puncture zones (in direct contact with projections) showed a reduction in the observed fluorescence lifetimes to between ~518–583 ps. The ratio of free-bound NAD(P)H (α1/α2) in unaffected areas of the viable epidermis was ~2.5–3.0, whereas the ratio at puncture holes was almost double at ~4.2–4.6. An exploratory pilot in vivo study also suggested similar closure rate with histamine administration to the forearms of human volunteers after Nanopatch® treatment, although a prolonged inflammation was observed with Tissue Viability Imaging. Overall, this work shows that the pores created by the microneedle-type medical device, Nanopatch®, are transient, with the skin recovering rapidly within 1–2 days in the epidermis after application.